Prestige Consumer Healthcare (PBH) Income towards Parent Company (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Income towards Parent Company of $46.7 million in Q4 2025, up 10.63% quarter-over-quarter from $42.2 million in Q3 2025, and down 23.49% on a YoY basis from $61.0 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Income towards Parent Company (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Income towards Parent Company history runs 16 years deep, the most recent figure standing at $46.7 million for Q4 2025.
- In Q4 2025, Income towards Parent Company fell 23.49% year-over-year to $46.7 million; the TTM figure through Dec 2025 stood at $186.5 million (down 12.82% YoY), while the FY2025 annual figure was $214.6 million, up 2.52% from the prior year.
- Income towards Parent Company was $46.7 million for Q4 2025 at Prestige Consumer Healthcare, up from $42.2 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $61.0 million in Q4 2024 to a low of -$240.6 million in Q1 2023.
- Historically, Income towards Parent Company has averaged $35.9 million across 5 years, with a median of $50.6 million in 2021.
- The sharpest annual moves came in 2023 and 2024: Income towards Parent Company plunged 561.84% in 2023, then soared 120.56% in 2024.
- A 5-year view of Income towards Parent Company shows it stood at $50.2 million in 2021, then increased by 3.46% to $52.0 million in 2022, then grew by 2.11% to $53.0 million in 2023, then grew by 15.05% to $61.0 million in 2024, then dropped by 23.49% to $46.7 million in 2025.
- The last three Income towards Parent Company figures came in at $46.7 million (Q4 2025), $42.2 million (Q3 2025), and $47.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Prestige Consumer Healthcare | 2.39 Bn | 2.33 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46.70 Mn |
| Sep 30, 2025 | 42.21 Mn |
| Jun 30, 2025 | 47.47 Mn |
| Mar 31, 2025 | 50.13 Mn |
| Dec 31, 2024 | 61.03 Mn |
| Sep 30, 2024 | 54.38 Mn |
| Jun 30, 2024 | 49.07 Mn |
| Mar 31, 2024 | 49.46 Mn |
| Dec 31, 2023 | 53.05 Mn |
| Sep 30, 2023 | 53.56 Mn |
| Jun 30, 2023 | 53.28 Mn |
| Mar 31, 2023 | -240.55 Mn |
| Dec 31, 2022 | 51.95 Mn |
| Sep 30, 2022 | 51.02 Mn |
| Jun 30, 2022 | 55.27 Mn |
| Mar 31, 2022 | 52.09 Mn |
| Dec 31, 2021 | 50.22 Mn |
| Sep 30, 2021 | 45.33 Mn |
| Jun 30, 2021 | 57.76 Mn |
| Mar 31, 2021 | 35.51 Mn |